OKAYAMA UNIVERSITY HOSPITAL

From the Head of Center for Advanced Heart Failure

The number of patients with heart failure is increasing. In the treatment of severe heart failure, the number of patients receiving mechanical circulatory support using an Impella or left ventricular assist device is increasing. The number of patients treated with catheterization for severe valvular heart disease and disease-specific pharmacotherapy for refractory cardiomyopathy is also increasing as treatment for the cause of heart failure. The center will continue its efforts to provide gentle and personalized treatment for critically ill patients.
 
Center Director's name: Yoshinobu Maeda
 

What is the Division of Center for Advanced Heart Failure?

The mission of the Center for Advanced Heart Failure is to contribute to the improvement of the health of the community and society by providing advanced, individualized treatment for people with severe heart failure in a safe, reliable, and gentle manner by our expert staff. Specifically, we provide mechanical circulatory support using Impella and left ventricular assist device, catheter therapy for severe valvular heart disease as a treatment for the causes of heart failure, and disease-specific drug therapy for refractory cardiomyopathy.
We provide team care by the Department of Cardiovascular Medicine, Department of Cardiovascular Surgery, Department of Anesthesiology and Resuscitation, Department of Emergency Medicine, Department of Palliative and Supportive Medicine, Department of Pediatric Cardiology, Department of Nursing, Department of Rehabilitation, Department of Clinical Engineering, Department of Pharmacy, IVR Center, Adult Congenital Heart Disease Center, and Organ Transplant Medical Center and Coordinator.